A pharma business lifer who loves working to bring treatments to patients; husband and father to a loving family; and a general news and politics addict.
@heypocket I installed the Pocket app on my iPhone and tried signing in. I entered my email and pressed Send Code, but nothing happened. What should I do?
On Wednesday, August 6 at 4:30 p.m. ET, $ELDN will host a conference call to review the updated Phase 1b data in #KidneyTransplantation being presented at #WTC2025. See our press release for conference call details: https://t.co/gnsX8br2KM
Peptides. What the hell are peptides and why is every gym bro, #MAHA wellness influencer and $HIMS executive pitching them?
STAT's Alex Hogan delves into the murky world of "peptides" in this great video. Must watch.
https://t.co/IaY53W5W9O
We are proud to have played a role in another historic milestone in #xenotransplantation with the first-ever #transplant of a genetically modified kidney from a pig to a human, conducted by the medical team at @MassGeneralNews. Learn more: https://t.co/gO090Oqj9i $ELDN
Had not thought about the ecosystem for AI testing like this!!
How can we keep AI from breaking free of human control? Regulation won‘t keep up, says former Google CEO Eric Schmidt—we need tech firms competing to improve ways to rein in AI https://t.co/EB4KCySVUl via @WSJ
Today we provided an outlook on our milestones for this year and highlighted the key achievements from 2023 in our press release coinciding with the 42nd Annual @JPMorgan Healthcare Conference https://t.co/sOCnd8Ei0V $ELDN #JPM2024
Are you interested in participating in a PMM study? click the link for more information and details on the study from Clinical Outcomes Solutions. https://t.co/P92elLgKHW
A sign of fundamental innovation is the breadth of attention received. Great to see outlets like @nytimes & @CNN cover @UMmedschool’s recent #xenotransplant using $ELDN’s anti-CD40L #tegoprubart in the investigational protocol, and exciting to also be covered by @NHF_Magazine!
Today we announced the first participant has been dosed in the $ELDN Phase 2 BESTOW trial for the prevention of organ rejection in patients receiving a #kidneytransplant. Read the press release here: https://t.co/zsccLW1Qh0 #CD40L#biopharma#pharmaceuticals
We appreciate all of the support from @ReneoPharma! Watch to learn more about this Energy for Life Walkathon National Sponsor and the latest on their Stride study for patients with Primary Mitochondrial Myopathy.
The keynote speakers at the RARE Health Equity Forum: Mario Estevez & Esther Lucero, will both examine the historical aspects of racial and cultural inequities in healthcare. To read more: https://t.co/xfmHrAGARa
#HealthEquityForum#RDDC#SanDiego#DiversityandInclusion
Sleep deprivation is now linked to more rapid brain aging. And other reasons to get a good night's rest, according to @austinperlmd https://t.co/fUzMOQ3RMS
@elonmusk Think of all the billable hours from the law firm, just deciphering what is fairly from unfairly treated. This is nearly a full employment for lawyers comment…
Join us today at 12:00pm EST for our Weekly Support Call. Our support call creates a safe and confidential place to connect and share with others living with mito. https://t.co/YS6e0pj0kb
We hear every year how helpful members of Congress find it to hear how policies come to life for their constituents. Plan to join us for Capitol Hill Days on September 19 and 20. Get the details in our latest Advocacy Update: https://t.co/V6sMR9f6Xv